Residency · Tulsa, OK
Sponsored by University of Oklahoma School of Community Medicine, at Tulsa
Nutritional considerations with antiobesity medications.
Obesity (Silver Spring, Md.) · 2024 · 96 citations · Jesse Richards
Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: A retrospective cohort study.
Obesity pillars · 2023 · 73 citations · Jesse Richards, Zhamak Khorgami
The American Society for Metabolic and Bariatric Surgery (ASMBS) updated position statement on perioperative venous thromboembolism prophylaxis in bariatric surgery.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2022 · 62 citations · Zhamak Khorgami
Significant Decrease in Alcohol Use Disorder Symptoms Secondary to Semaglutide Therapy for Weight Loss: A Case Series.
The Journal of clinical psychiatry · 2023 · 54 citations · Jesse Richards, Lana Mnajjed
Defining Hyperphagia for Improved Diagnosis and Management of MC4R Pathway-Associated Disease: A Roundtable Summary.
Current obesity reports · 2025 · 18 citations · Jesse Richards
Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis.
Obesity reviews : an official journal of the International Association for the Study of Obesity · 2024 · 28 citations · Jesse Richards, Zhamak Khorgami
Highway to the danger zone? A cautionary account that GLP-1 receptor agonists may be too effective for unmonitored weight loss.
Obesity reviews : an official journal of the International Association for the Study of Obesity · 2024 · 29 citations · Jesse Richards
Use of GLP-1 agonists in high risk patients prior to bariatric surgery: a cohort study.
Surgical endoscopy · 2023 · 44 citations · Jessica Heard, James McClintic, Zhamak Khorgami, Jesse Richards, Geoffrey Chow